Assessing adaptation of the cancer kinome in response to targeted therapies

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Protein kinases are crucial for cancer cell proliferation and survival, making them key therapeutic targets.
• Current kinase inhibitors show limited success due to cancer cells' resilience and ability to develop resistance.
• Tumor resistance often arises from adaptive reprogramming of cellular signaling networks.

Purpose of the Study:

• To develop and validate a novel platform for analyzing the activity of the entire kinome.
• To investigate adaptive kinase responses in cancer cells upon targeted inhibition.
• To identify mechanisms of resistance to kinase inhibitors for improved therapeutic strategies.

Main Methods:

• Development of multiplexed inhibitor beads (MIBs) with immobilized inhibitors that bind activated kinases.
• Coupling MIB capture with mass spectrometry (MIB-MS) for high-throughput kinome activity profiling.
• Analysis of over 75% of the expressed kinome to assess simultaneous kinase activity.

Main Results:

• The MIB-MS platform enables simultaneous determination of kinase activity across a significant portion of the kinome.
• Adaptive responses, including transcriptional up-regulation of bypass kinases, were identified.
• These adaptive mechanisms contribute to tumor resistance against targeted kinase inhibition.

Conclusions:

• Understanding kinome reprogramming is essential for overcoming therapeutic resistance.
• The MIB-MS platform provides a powerful tool for dissecting adaptive signaling in cancer.
• This research facilitates the development of novel therapeutic strategies for durable clinical responses in cancer patients.